Antikor: Fighting cancer with better accuracy

Antikor have developed a new type of cancer treatment - based on Antibody Drug Conjugates (ADC) which are already established.

Their next-generation Antibody Fragment Drug Conjugates (FDC) are smaller and more accurate than previous forms, and can better penetrate solid tumours and effectively destroy cancer cells. The treatment doesn't have the same nasty side effects as Chemotherapy or conventional ADCs either!

Antikor are raising £500k to facilitate the development of their product towards the market. The equity investment campaign can be found on the Capital Cell platform: https://capitalcell.co.uk/campaign/antikor/

CapitalAtRisk

Тэги:

#cancer_treatment #novel_technology #biotech #biotechnology #healthcare #medical_advancements #cancer_therapy #investment #invest_in_startups #equity_investment #eis_investment

Скачать видео